The Medical Aesthetic industry’s secret weapon: real-time data from Qsight. Gain instant access to market data, valuable practitioner and patient insights, and powerful sales tools—right when you need them.
Stay Ahead in the Dynamic Aesthetics Market with Guidepoint Qsight’s Cutting-Edge Intelligence
Guidepoint Qsight brings a new era of intelligence to the Medical Aesthetics industry. In a rapidly growing and ever-evolving market, organizations selling into or interested in tracking the aesthetics space face the challenge of lacking essential data. Our comprehensive suite of data and analytics solutions provides the critical insights and assurance needed to proactively respond to these changes and stay ahead of the competition. With Guidepoint Qsight, you gain the knowledge and tools necessary to overcome decision-making blind spots.
Explore Our Product Offerings Designed Specifically for Aesthetic Manufacturers
FAQs: How We Can Help Aesthetic Manufacturers
Qsight offers comprehensive data on the Medical Aesthetics market, including insights into overall market dynamics, growth trends, and segment-specific performance. This helps organizations understand the scope and trajectory of the market to make informed business decisions.
We use real-time point-of-sale transactional data feeds to monitor sales trends and brand market share. This allows businesses to gauge their competitive positioning and understand market penetration effectively, enabling them to adjust strategies in response to market movements.
Qsight provides detailed market insights and comparisons to help businesses identify potential markets for expansion. The insights are designed to prioritize opportunities based on profitability and strategic fit, supporting data-driven decision-making for geographic and market segment expansion.
We enhance sales strategies with our Qsight Prospector tool, which offers comprehensive and validated sales enablement information, including aesthetics practice location-based details, contact information, and offered treatments, services, and products. This targeted outreach and streamlined lead qualification process help businesses optimize their sales efforts.
The Practitioner Tracker provides longitudinal, quantitative survey-based research to understand practitioner sentiment and patient demand. Combined with the Sales Measurement tool, which leverages real-time point-of-sale data, businesses can deeply understand market dynamics at the segment, brand, patient, and practice levels. This leads to more effective decision-making and strategy formulation.
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
Lightning Strikes the Peripheral Thrombectomy Market: Examining the Rise of Penumbra and the Impact of Innovative Devices
The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Rapid Ascend: Axonics Gains Ground in the SNM Market Amid F15 Launch and Next-Gen R20 System Arrival
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.
Medical Aesthetics Industry Faces Economic Uncertainty: Putting the “Lipstick Effect” to the Test
As 2023 began with lingering economic concerns from 2022 (inflation, rising interest rates, risk of recession, etc.), the aesthetics industry’s hope for continued strong growth may be challenged.
TAVR: A Turbulent Journey Through Pandemic Recovery
With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.